China Animal Husbandry and Veterinary Medicine ›› 2024, Vol. 51 ›› Issue (3): 1203-1213.doi: 10.16431/j.cnki.1671-7236.2024.03.032
• Preventive Veterinary Medicine • Previous Articles
WU Wei1,2,3, HAO Fei1,3, XIE Xing1,2,3, FENG Zhixin1,2,3
Received:
2023-08-17
Published:
2024-02-27
CLC Number:
WU Wei, HAO Fei, XIE Xing, FENG Zhixin. Research Progress on Atomized Vaccines[J]. China Animal Husbandry and Veterinary Medicine, 2024, 51(3): 1203-1213.
[1] 冯志新.疫苗气溶胶免疫技术研究进展[J].中国兽药杂志, 2021, 55(6):53-60. FENG Z X.Research progress of aerosol vaccination technology[J].Chinese Journal of Veterinary Drug, 2021, 55(6):53-60.(in Chinese) [2] SUDDUTH E R, TRAUTMANN-RODRIGUEZ M, GILL N, et al.Aerosol pulmonary immune engineering[J].Advanced Drug Delivery Reviews, 2023, 199:114831. [3] GOUGH R E, ALEXANDER D J.The speed of resistance to challenge induced in chickens vaccinated by different routes with a b1 strain of live NDV[J].The Veterinary Record, 1973, 92(21):563-564. [4] GOUGH R E, ALLAN W H.The potential as an aerosol vaccine of ulster 2c strain, Newcastle disease virus[J].The Veterinary Record, 1974, 95(12):263-265. [5] KIM S J, SPRADBROW P B.Administration of a vaccine prepared from the australian v4 strain of Newcastle disease virus by aerosol and drinking water[J].Australian Veterinary Journal, 1978, 54(10):486-489. [6] SCHALKOORT R, SPRADBROW P B.Aerosol vaccination of chickens with the v4 strain of Newcastle disease virus[J].Australian Veterinary Journal, 1980, 56(9):429-433. [7] MEBRAHTU K, TESHALE S, ESATU W, et al.Evaluation of spray and oral delivery of Newcastle disease i2 vaccine in chicken reared by smallholder farmers in Central Ethiopia[J].BMC Veterinary Research, 2018, 14(1):48. [8] 李清艳,翟向和,史书军,等.气雾免疫在养禽生产中的应用[J].养禽与禽病防治, 2006, 7:37-38. LI Q Y, ZHAI X H, SHI S J, et al.Application of aerosol immunization in poultry production[J].Poultry Husbandry and Disease Control, 2006, 7:37-38.(in Chinese) [9] 李济清.鸡新城疫Ⅰ系苗气雾免疫效果好[J].湖南畜牧兽医, 1997, 5:21. LI J Q.The aerosol immunization effect of Newcastle disease Ⅰ vaccine is good[J].Hunan Journal of Animal Science&Veterinary Medicine, 1997, 5:21.(in Chinese) [10] 魏建平,郭鑫,杨汉春.不同免疫途径对肉鸡新城疫气管粘膜抗体的影响[J].中国禽业导刊, 2004, 16:20-21. WEI J P, GUO X, YANG H C.Effects of different immune routes on tracheal mucosal antibodies against Newcastle disease in broilers[J].Guide to Chinese Poultry, 2004, 16:20-21.(in Chinese) [11] CORBANIE E A, REMON J P, VAN REETH K, et al.Spray drying of an attenuated live Newcastle disease vaccine virus intended for respiratory mass vaccination of poultry[J].Vaccine, 2007, 25(49):8306-8317. [12] CORIA M F.Protective effect of an inactivated Avian coronavirus vaccine administered by aerosol[J].Archiv Fur Die Gesamte Virusforschung, 1973, 41(1):66-70. [13] DEUTER A, SOUTHEE D J, MOCKETT A P.Fowlpox virus:Pathogenicity and vaccination of day-old chickens via the aerosol route[J].Research in Veterinary Science, 1991, 50(3):362-364. [14] BAGHERI S, MITRA T, PAUDEL S, et al.Aerosol vaccination of chicken pullets with irradiated avian pathogenic Escherichia coli induces a local immunostimulatory effect[J].Frontiers in Immunology, 2023, 14:1185232. [15] GAVRILOV N, PETKOV P, MERMERSKI K.Use of lapinized "C" vaccine as aerosol in immunoprophylaxis against swine fever[J].Archiv Fur Experimentelle Veterinarmedizin, 1980, 34(1):73-78. [16] 崔显义.猪瘟气雾免疫研究概况[J].兽医导刊, 1983, 2:36-41. CUI X Y.General situation of aerosol immunization of classical swine fever[J].Veterinary Orientation, 1983, 2:36-41.(in Chinese) [17] 沈阳市科学技术局.气雾免疫法预防猪瘟[J].新农业, 1976, 8:29. SHENYANG BUREAU OF SCIENCE AND TECHNOLOGY.Prevention of classical swine fever by aerosol immunization[J].Modern Agriculture, 1976, 8:29.(in Chinese) [18] 沈阳市于洪区畜牧兽医站,辽宁大学生物系,沈阳市蔬菜农场.猪瘟气雾免疫[J].新农业, 1978, 19:27-28. SHENYANG YUHONG DISTRICT ANIMAL HUSBANDRY AND VETERINARY STATION, DEPARTMENT OF BIOLOGY, LIAONING UNIVERSITY, SHENYANG VEGETABLE FARM.Aerosol immunization of classical swine fever[J].Modern Agriculture, 1978, 19:27-28.(in Chinese) [19] 辽宁省兽医卫生站.猪瘟兔化弱毒细胞苗与猪瘟兔化弱毒疫苗气雾免疫试验报告[J].辽宁畜牧兽医, 1980, 2:4-6. LIAONING PROVINCIAL VETERINARY HEALTH STATION.Experimental report on aerosol immunization of attenuated cell vaccine of classical swine fever and attenuated vaccine of classical swine fever[J].Liaoning Journal of Animal Husbandry and Veterinary Medicine, 1980, 2:4-6.(in Chinese) [20] 郭全胜,刘深庭,于春叶,等.猪瘟气雾免疫实验研究[J].畜禽业, 2004, 6:39. GUO Q S, LIU S T, YU C Y, et al.Experimental study on aerosol immunity of classical swine fever[J].Livestock and Poultry Industry, 2004, 6:39.(in Chinese) [21] KATINGER A, LUBITZ W, SZOSTAK M P, et al.Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses[J].Journal of Biotechnology, 1999, 73(2-3):251-260. [22] MURPHY D, VAN ALSTINE W G, CLARK L K, et al.Aerosol vaccination of pigs against Mycoplasma hyopneumoniae infection[J].American Journal of Veterinary Research, 1993, 54(11):1874-1880. [23] FENG Z X, WEI Y N, LI G L, et al.Development and validation of an attenuated Mycoplasma hyopneumoniae aerosol vaccine[J].Veterinary Microbiology, 2013, 167(3-4):417-424. [24] HAO F, BAI Y, XIE X, et al.Phenotypic characteristics and protective efficacy of an attenuated Mycoplasma hyopneumoniae vaccine by aerosol administration[J].Vaccine, 2022, 40(42):6074-6083. [25] 牛青青.猪肺炎支原体超声雾化活疫苗的发生与初步鉴定[D].太谷:山西农业大学, 2016. NIU Q Q.Development and identification of an attenuated Mycoplasma hyopneumoniae aerosol vaccine produced by the ultrasonic method[D].Taigu:Shanxi Agricultural University, 2016.(in Chinese) [26] 郑鹏.猪支原体肺炎活疫苗rm48株气雾免疫技术的研究[D].泰安:山东农业大学, 2016. ZHENG P.Research on live vaccine RM48 of MPS using by aerosol immunization technique[D].Tai'an:Shandong Agricultural University, 2016.(in Chinese) [27] 郝飞,白昀,袁厅,等.猪支原体肺炎活疫苗与灭活疫苗联合免疫效果评价[J].中国动物传染病学报, 2023, 31(4):88-94. HAO F, BAI Y, YUAN T, et al.Evaluation of the prime-boost strategy with attenuated vaccine and inactivated vaccine against Mycoplasma hyopneumoniae[J].Chinese Journal of Animal Infectious Diseases, 2023, 31(4):88-94.(in Chinese) [28] ZHAI L N, ZHAO Y, SONG X L, et al.Inhalable vaccine of bacterial culture supernatant extract mediates protection against fatal pulmonary anthrax[J].Emerging Microbes&Infections, 2023, 12(1):2191741. [29] GAN C, LUO W, YU Y, et al.Intratracheal inoculation of ahc vaccine induces protection against aerosolized botulinum neurotoxin a challenge in mice[J].NPJ Vaccines, 2021, 6(1):87. [30] SONG X, ZHANG W, ZHAI L, et al.Aerosolized intratracheal inoculation of recombinant protective antigen (rPA) vaccine provides protection against inhalational anthrax in B10.D2-Hc0 mice[J].Frontiers in Immunology, 2022, 13:819089. [31] 祁文光,胡平,陈友信,等.四种疫(菌)苗对牦牛联合气雾免疫的研究--1.口蹄疫弱毒IB-RS2猪肾传代细胞疫苗对牦牛气雾免疫试验[J].青海畜牧兽医杂志, 1982, 4:39-45. QI W G, HU P, CHEN Y X, et al.Study on the combined aerosol immunity of four kinds of epidemic (bacterial) vaccines to yak--1.Aerosol immunity test of attenuated foot-and-mouth disease IB-RS2 porcine kidney cell vaccine to yak[J].Chinese Qinghai Journal of Animal and Veterinary Sciences, 1982, 4:39-45.(in Chinese) [32] MANN D D, BUENING G M, THORNE J G.Efficacy of aerosol, intranasal and intramuscular vaccination against selected bovine viral diseases[J].The Cornell Veterinarian, 1983, 73(4):375-379. [33] MAINA T W, GREGO E A, BOGGIATTO P M, et al.Applications of nanovaccines for disease prevention in cattle[J].Frontiers in Bioengineering and Biotechnology, 2020, 8:608050. [34] BASSEL L L, CO C, MACDONALD A, et al.Pulmonary and systemic responses to aerosolized lysate of Staphylococcus aureus and Escherichia coli in calves[J].BMC Veterinary Research, 2020, 16(1):168. [35] SABIN A B.Immunization against measles by aerosol[J].Reviews of Infectious Diseases, 1983, 5(3):514-523. [36] CUTTS F T, CLEMENTS C J, BENNETT J V.Alternative routes of measles immunization:A review[J].Biologicals, 1997, 25(3):323-338. [37] DÍAZ-ORTEGA J L, BENNETT J V, CASTAÑEDA-DESALES D, et al.Booster immune response in children 6-7 years of age, randomly assigned to four groups with two mmr vaccines applied by aerosol or by injection[J].Vaccine, 2014, 32(29):3680-3686. [38] DILRAJ A, CUTTS F T, DE CASTRO J F, et al.Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren:A randomised trial[J].Lancet(London, England), 2000, 355(9206):798-803. [39] DILRAJ A, SUKHOO R, CUTTS F T, et al.Aerosol and subcutaneous measles vaccine:Measles antibody responses 6 years after re-vaccination[J].Vaccine, 2007, 25(21):4170-4174. [40] GRIFFIN D E.Current progress in pulmonary delivery of measles vaccine[J].Expert Review of Vaccines, 2014, 13(6):751-759. [41] HIREMATH G S, OMER S B.A meta-analysis of studies comparing the respiratory route with the subcutaneous route of measles vaccine administration[J].Human Vaccines, 2005, 1(1):30-36. [42] LOW N, KRAEMER S, SCHNEIDER M, et al.Immunogenicity and safety of aerosolized measles vaccine:Systematic review and Meta-analysis[J].Vaccine, 2008, 26(3):383-398. [43] OMER S B, HIREMATH G S, HALSEY N A.Respiratory administration of measles vaccine[J].Lancet(London, England), 2010, 375(9716):706-708. [44] WONG-CHEW R M, GARCÍA-LEÓN M L, ESPINOSA-TORRES TORRIJA B, et al.Increasing the time of exposure to aerosol measles vaccine elicits an immune response equivalent to that seen in 9-month-old mexican children given the same dose subcutaneously[J].The Journal of Infectious Diseases, 2011, 204(3):426-432. [45] DE SWART R L, DE VRIES R D, RENNICK L J, et al.Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protection[J].NPJ Vaccines, 2017, 2:22. [46] LICALSI C, CHRISTENSEN T, BENNETT J V, et al.Dry powder inhalation as a potential delivery method for vaccines[J].Vaccine, 1999, 17(13-14):1796-1803. [47] LICALSI C, MANIACI M J, CHRISTENSEN T, et al.A powder formulation of measles vaccine for aerosol delivery[J].Vaccine, 2001, 19(17-19):2629-2636. [48] COHEN B J, PARRY R P, ANDREWS N, et al.Laboratory methods for assessing vaccine potency retained in aerosol outputs from nebulizers:Application to world health organization measles aerosol project[J].Vaccine, 2008, 26(27-28):3534-3539. [49] REYNARD O, GONZALEZ C, DUMONT C, et al.Nebulized fusion inhibitory peptide protects cynomolgus macaques from Measles virus infection[J].Nature Communications, 2022, 13(1):6439. [50] AGARKHEDKAR S, KULKARNI P S, WINSTON S, et al.Safety and immunogenicity of dry powder measles vaccine administered by inhalation:A randomized controlled phase Ⅰ clinical trial[J].Vaccine, 2014, 32(50):6791-6797. [51] EDMONDSON W P JR, ROTHENBERG R, WHITE P W, et al.A comparison of subcutaneous, nasal, and combined influenza vaccination.Ⅱ.Protection against natural challenge[J].American Journal of Epidemiology, 1971, 93(6):480-486. [52] GRUBER W C, HINSON H P, HOLLAND K L, et al.Comparative trial of large-particle aerosol and nose drop administration of live attenuated influenza vaccines[J].The Journal of Infectious Diseases, 1993, 168(5):1282-1285. [53] VATZIA E, ALLEN E R, MANJEGOWDA T, et al.Respiratory and intramuscular immunization with ChAdOx2-NPM1-NA induces distinct immune responses in H1N1 pdm09 pre-exposed pigs[J].Frontiers in Immunology, 2021, 12:763912. [54] MARTINI V, PAUDYAL B, CHRUN T, et al.Simultaneous aerosol and intramuscular immunization with influenza vaccine induces powerful protective local T cell and systemic antibody immune responses in pigs[J].Journal of Immunology(Baltimore, Md:1950), 2021, 206(3):652-663. [55] MORGAN S B, HEMMINK J D, PORTER E, et al.Aerosol delivery of a candidate universal influenza vaccine reduces viral load in pigs challenged with pandemic H1N1 virus[J].Journal of Immunology(Baltimore, Md:1950), 2016, 196(12):5014-5023. [56] JEMSKI J V, WALKER J S.Aerosol vaccination of mice with a live, temperature-sensitive recombinant Influenza virus[J].Infection and Immunity, 1976, 13(3):818-824. [57] SMITH J H, BROOKS P, JOHNSON S, et al.Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice[J].Vaccine, 2011, 29(14):2568-2575. [58] SONG K, BOLTON D L, WEI C J, et al.Genetic immunization in the lung induces potent local and systemic immune responses[J].Proceedings of the National Academy of Sciences of the United States of America, 2010, 107(51):22213-22218. [59] ROSENTHAL S R, MCENERY J T, RAISYS N.Aerogenic BCG vaccination against tuberculosis in animal and human subjects[J].The Journal of Asthma Research, 1968, 5(4):309-323. [60] MANJALY THOMAS Z R, SATTI I, MARSHALL J L, et al.Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A:A phase Ⅰ randomised controlled trial[J].PLoS Medicine, 2019, 16(4):e1002790. [61] MANJALY THOMAS Z R, MCSHANE H.Aerosol immunisation for TB:Matching route of vaccination to route of infection[J].Transactions of the Royal Society of Tropical Medicine and Hygiene, 2015, 109(3):175-181. [62] BARCLAY W R, BUSEY W M, DALGARD D W, et al.Protection of monkeys against airborne tuberculosis by aerosol vaccination with Bacillus calmette-guerin[J].The American Review of Respiratory Disease, 1973, 107(3):351-358. [63] NUERMBERGER E L, YOSHIMATSU T, TYAGI S, et al.Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG[J].Infection and Immunity, 2004, 72(2):1065-1071. [64] WHITE A D, SIBLEY L, DENNIS M J, et al.Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques[J].Clinical and Vaccine Immunology, 2013, 20(5):663-672. [65] SATTI I, MEYER J, HARRIS S A, et al.Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults:A phase 1, double-blind, randomised controlled trial[J].The Lancet Infectious Diseases, 2014, 14(10):939-946. [66] HOKEY D A, WACHHOLDER R, DARRAH P A, et al.A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/AD35 vaccine:Evidence for transient T cell responses in peripheral blood and robust sustained responses in the lungs[J].Human Vaccines&Immunotherapeutics, 2014, 10(8):2199-2210. [67] JEYANATHAN M, FRITZ D K, AFKHAMI S, et al.Aerosol delivery, but not intramuscular injection, of Adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans[J].JCI Insight, 2022, 7(3):e155655. [68] GAUTAM U S, ASRICAN R, SEMPOWSKI G D.Targeted dose delivery of Mycobacterium tuberculosis in mice using silicon antifoaming agent via aerosol exposure system[J].PLoS One, 2022, 17(10):e0276130. [69] WHITE A D, SIBLEY L, SARFAS C, et al.Influence of aerosol delivered BCG vaccination on immunological and disease parameters following SARS-CoV-2 challenge in Rhesus macaques[J].Frontiers in Immunology, 2021, 12:801799. [70] DAVIES B, PRIER J E, JONES C M, et al.Cutting edge:Tissue-resident memory T cells generated by multiple immunizations or localized deposition provide enhanced immunity[J].Journal of Immunology(Baltimore, Md:1950), 2017, 198(6):2233-2237. [71] SHIN H, IWASAKI A.A vaccine strategy that protects against genital herpes by establishing local memory T cells[J].Nature, 2012, 491(7424):463-467. [72] XU F, WU S, YI L, et al.Safety, mucosal and systemic immunopotency of an aerosolized Adenovirus-vectored vaccine against SARS-CoV-2 in rhesus macaques[J].Emerging Microbes & Infections, 2022, 11(1):438-441. [73] WU S, HUANG J, ZHANG Z, et al.Safety, tolerability, and immunogenicity of an aerosolised Adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCOV) in adults:Preliminary report of an open-label and randomised phase 1 clinical trial[J].The Lancet Infectious Diseases, 2021, 21(12):1654-1664. [74] ZHONG J, LIU S, CUI T, et al.Heterologous booster with inhaled Adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants[J].Emerging Microbes&Infections, 2022, 11(1):2689-2697. [75] WANG F Z, ZHANG C H, TANG L, et al.An observational prospective cohort study of vaccine effectiveness against SARS-CoV-2 infection of an aerosolized, inhaled Adenovirus-type-5-vectored COVID-19 vaccine given as a second booster dose in Guangzhou city, China[J].The Journal of Infectious Diseases, 2023.Doi:10.1093/infdis/jiad338. [76] WANG F, HUANG B, DENG Y, et al.Neutralizing antibody levels associated with injectable and aerosolized Ad5-nCOV boosters and BA.2 infection[J].BMC Medicine, 2023, 21(1):233. [77] ROH E H, FROMEN C A, SULLIVAN M O.Inhalable mRNA vaccines for respiratory diseases:A roadmap[J].Current Opinion in Biotechnology, 2022, 74:104-109. [78] CORBETT M, BOGERS W M, HEENEY J L, et al.Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic[J].Proceedings of the National Academy of Sciences of the United States of America, 2008, 105(6):2046-2051. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||